113 related articles for article (PubMed ID: 10099121)
1. Immunity to rotavirus infection in mice.
Franco MA; Greenberg HB
J Infect Dis; 1999 May; 179 Suppl 3():S466-9. PubMed ID: 10099121
[TBL] [Abstract][Full Text] [Related]
2. The memory B cell subset responsible for the secretory IgA response and protective humoral immunity to rotavirus expresses the intestinal homing receptor, alpha4beta7.
Williams MB; Rosé JR; Rott LS; Franco MA; Greenberg HB; Butcher EC
J Immunol; 1998 Oct; 161(8):4227-35. PubMed ID: 9780197
[TBL] [Abstract][Full Text] [Related]
3. Immunity to rotavirus in T cell deficient mice.
Franco MA; Greenberg HB
Virology; 1997 Nov; 238(2):169-79. PubMed ID: 9400590
[TBL] [Abstract][Full Text] [Related]
4. Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice.
McNeal MM; Barone KS; Rae MN; Ward RL
Virology; 1995 Dec; 214(2):387-97. PubMed ID: 8553539
[TBL] [Abstract][Full Text] [Related]
5. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.
Feng N; Lawton JA; Gilbert J; Kuklin N; Vo P; Prasad BV; Greenberg HB
J Clin Invest; 2002 May; 109(9):1203-13. PubMed ID: 11994409
[TBL] [Abstract][Full Text] [Related]
7. Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice.
McNeal MM; Basu M; Bean JA; Clements JD; Choi AH; Ward RL
Virology; 2007 Jul; 363(2):410-8. PubMed ID: 17337285
[TBL] [Abstract][Full Text] [Related]
8. Rotavirus vaccines: how they work or don't work.
Ward RL
Expert Rev Mol Med; 2008 Feb; 10():e5. PubMed ID: 18267049
[TBL] [Abstract][Full Text] [Related]
9. Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion.
Corthésy B; Benureau Y; Perrier C; Fourgeux C; Parez N; Greenberg H; Schwartz-Cornil I
J Virol; 2006 Nov; 80(21):10692-9. PubMed ID: 16956954
[TBL] [Abstract][Full Text] [Related]
10. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
Tamura S; Kurata T
Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
[TBL] [Abstract][Full Text] [Related]
11. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles.
Herrmann JE; Chen SC; Jones DH; Tinsley-Bown A; Fynan EF; Greenberg HB; Farrar GH
Virology; 1999 Jun; 259(1):148-53. PubMed ID: 10364499
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of protection against rotavirus infection and disease.
Ward R
Pediatr Infect Dis J; 2009 Mar; 28(3 Suppl):S57-9. PubMed ID: 19252425
[TBL] [Abstract][Full Text] [Related]
13. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice.
Franco MA; Greenberg HB
J Virol; 1995 Dec; 69(12):7800-6. PubMed ID: 7494291
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.
Dennehy M; Bourn W; Steele D; Williamson AL
Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069
[TBL] [Abstract][Full Text] [Related]
15. Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon.
Franco MA; Tin C; Rott LS; VanCott JL; McGhee JR; Greenberg HB
J Virol; 1997 Jan; 71(1):479-86. PubMed ID: 8985374
[TBL] [Abstract][Full Text] [Related]
16. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.
Burns JW; Siadat-Pajouh M; Krishnaney AA; Greenberg HB
Science; 1996 Apr; 272(5258):104-7. PubMed ID: 8600516
[TBL] [Abstract][Full Text] [Related]
18. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
19. Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice.
Dharakul T; Labbe M; Cohen J; Bellamy AR; Street JE; Mackow ER; Fiore L; Rott L; Greenberg HB
J Virol; 1991 Nov; 65(11):5928-32. PubMed ID: 1656079
[TBL] [Abstract][Full Text] [Related]
20. Characterization of homologous and heterologous rotavirus-specific T-cell responses in infant and adult mice.
Jaimes MC; Feng N; Greenberg HB
J Virol; 2005 Apr; 79(8):4568-79. PubMed ID: 15795243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
